Immunohistochemical Evaluation of Lumican Expression and Cellular Proliferation in Paired Eutopic and Ectopic Endometrium in Ovarian Endometriosis

Tuğba Ekiz-Yılmaz, Cevriye Cansız Ersöz, Duygu Enneli
In: Reproductive Medicine · 2026 · vol. 7(4) , pp. 53 · doi:10.3390/reprodmed7040053 · W7215071573
Observational OA: gold CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-10-03 ⓘ

In ovarian endometriosis, ectopic endometrium in the secretory phase exhibits increased lumican expression and sustained Ki-67 immunoreactivity compared to eutopic tissue, suggesting altered local microenvironmental dynamics without direct evidence of association between these markers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Background/Objectives: This study aimed to evaluate lumican (LUM), TGF-β1, and Ki-67 expression in eutopic and ectopic endometrial tissues across the proliferative and secretory phases of the menstrual cycle in women with ovarian endometriosis. Methods: Paired eutopic and ectopic endometrial tissues were retrospectively obtained from 16 women with ovarian endometrioma and classified as proliferative (n = 8) or secretory (n = 8). LUM, TGF-β1, and Ki-67 immunoreactivities were evaluated in glandular and stromal compartments and semi-quantitatively assessed using the H-score method. Results: While no difference was found in LUM expression between eutopic and ectopic tissues in the proliferative phase, a significant increase in immunoreactivity was observed in the epithelium and stroma of the ectopic endometrium in the secretory phase (p < 0.0001). Ki-67 expression was more prominent in the eutopic stroma and ectopic epithelium in the proliferative phase. In the secretory phase, while Ki-67 expression decreased in eutopic tissue, it continued at levels close to those in the proliferative phase in ectopic tissue and was found to be higher than in eutopic tissue (p < 0.0001). TGF-β1 immunoreactivity was observed only in smooth muscle cells and perivascular areas; no evaluable TGF-β1 immunoreactivity was detected in the endometrial epithelial or stromal compartments. Conclusions: In this exploratory cohort, increased LUM expression in secretory-phase ectopic endometrium was observed alongside sustained Ki-67 immunoreactivity. However, these parallel expression patterns should not be interpreted as evidence of a direct association between LUM and cellular proliferation. TGF-β1 immunoreactivity did not differ between eutopic and ectopic tissues. Given the established role of lumican in ECM biology, its altered expression may reflect differences in the local tissue microenvironment, although ECM remodeling was not directly assessed in the present study.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (28)

Source provenance

openalex
last seen: 2026-10-11T06:05:52.046646+00:00
License: CC0 · commercial use OK